Sestamibi is a lipophilic cationic imaging agent belonging to the triphenylphosphonium class, primarily used in nuclear medicine for myocardial perfusion imaging and the diagnostic localization of neuroendocrine… Read more
Sestamibi is a lipophilic cationic imaging agent belonging to the triphenylphosphonium class, primarily used in nuclear medicine for myocardial perfusion imaging and the diagnostic localization of neuroendocrine tumors. By accumulating in cells with high mitochondrial density, this agent facilitates the visualization of tissue perfusion and is instrumental in the diagnosis of ischemic heart disease. Analytical laboratories require high-quality reference standards of sestamibi and its related compounds, including pharmacopeial and non-pharmacopeial impurities, to support precise regulatory compliance. These materials, along with stable isotope-labelled compounds, are critical for rigorous impurity profiling, method validation, and ongoing quality control of pharmaceutical formulations. Maintaining access to such validated standards ensures accuracy in diagnostic imaging procedures and helps laboratories meet stringent pharmaceutical testing requirements throughout the product lifecycle.